GFRA1 and pancreatic neoplasm: MIA PaCa-2 human pancreatic cancer cells, which contain endogenous APE1, were treated with GDNF, a binding partner of GFRα1 to investigate the effect of GDNF on pancreatic cancer cell proliferation (Figure 1a).